HMY-1 Cells
545,10 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The HMY-1 cell line is a malignant melanoma cell line derived from a human male patient. The melanoma originated on the right sole of the patient and later metastasized to the lymph nodes. The cells exhibit a fibroblast-like morphology, characteristic of melanoma cells adapted for in vitro culture. Initially, the cell line exhibited pigmentation, a common trait in melanomas, but this pigmentation faded as the cell line became established and stabilized over time. Genetically, the HMY-1 cell line has a modal chromosome number of 66, indicating significant chromosomal abnormalities typical of cancer cells. The cell line demonstrates an infinite lifespan in culture, providing a valuable model for long-term studies on melanoma biology, metastasis, and therapeutic interventions. As with other melanoma cell lines, HMY-1 can be utilized for research into the mechanisms of melanoma progression, drug resistance, and the development of novel treatments targeting metastatic cancer cells. |
|---|---|
| Organisme | Human |
| Tissu | Skin |
| Maladie | Melanoma |
| Site métastatique | Left inguinal lymph node |
| Synonymes | HMY1 |
Caractéristiques
| Âge | 62 years |
|---|---|
| Genre | Male |
| Morphologie | Fibroblast |
| Propriétés de croissance | Adherent |
Données réglementaires
| Référence | HMY-1 (Cytion catalog number 305145) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_2950 |
Données biomoléculaires
| Tumorigène | Yes |
|---|
Manipulation
| Milieu de culture | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Réactif de dissociation | Accutase |
| Temps de doublement | 37 hours |
| Repiquage | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305145-051125 | Certificat d'analyse | 11. Dec. 2025 | 305145 |